Early evaluation for chemotherapy response of lung cancer using a new PET/CT tracer of DNA synthesis.
Not Applicable
- Conditions
- on-small cell lung caner
- Registration Number
- JPRN-UMIN000012322
- Lead Sponsor
- ational Center for Global Health and Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
Those who have not signed the informed consent form. Those who have symptomatic brain metastasis, or active double cancer, or active infectious disease, or spinal metastasis that required immediate surgery or radiotherapy, or uncontrollable hypertension, or ischemic heart disease, or uncontrollable diabetes. Those who have been decided not appropriate by the physician.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method If the tumor uptake reduction of 4DST after chemotherapy is larger and earlier than that of FDG or not.
- Secondary Outcome Measures
Name Time Method The correlation of the tumor uptake reductions of 4DST or FDG after chemotherapy and the tumor volume reduction, and the progression free survival.